Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Small Pharma Inc V.DMT

Healthcare
Small Pharma Inc. is a biotechnology company focused on short-duration psychedelic therapies for mental health conditions. The Company is focused on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions that are scalable, commercially differentiated, and conveniently dosed, with the goal of addressing key unmet needs in the treatment of... see more

Recent & Breaking News (TSXV:DMT)

TSX Venture Exchange Stock Maintenance Bulletins

Canada NewsWire October 24, 2023

Canadian Investment Regulatory Organization Trading Halt - DMT

Canada NewsWire October 23, 2023

Cybin Completes Acquisition of Small Pharma Inc. to Create International Clinical-stage Leader in Novel Psychedelic Therapeutics

Business Wire October 23, 2023

Small Pharma Reports Fiscal Second Quarter 2024 Highlights

GlobeNewswire October 19, 2023

Small Pharma Obtains Final Order Approving Arrangement

Business Wire October 17, 2023

Small Pharma Announces Voting Results from Annual General and Special Meeting of Shareholders

GlobeNewswire October 12, 2023

Disposition of Common Shares of Small Pharma Inc.

GlobeNewswire October 2, 2023

Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder

GlobeNewswire September 26, 2023

Canadian Investment Regulatory Organization Trade Resumption - DMT

Canada NewsWire August 28, 2023

Cybin to Acquire Small Pharma Inc.

Business Wire August 28, 2023

Canadian Investment Regulatory Organization Trading Halt - DMT

Canada NewsWire August 28, 2023

Small Pharma Reports Fiscal First Quarter 2024 Highlights

GlobeNewswire July 27, 2023

Small Pharma Announces SPL028 R&D Strategy Update

GlobeNewswire July 5, 2023

Small Pharma Announces Management Team Change

GlobeNewswire July 5, 2023

Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights

GlobeNewswire June 28, 2023

Small Pharma Announces Significant Developments In Intellectual Property Portfolio

GlobeNewswire May 25, 2023

Small Pharma to Present at Upcoming CINP World Congress of Neuropsychopharmacology

GlobeNewswire May 3, 2023

Small Pharma Announces Positive Six-month Data from Phase IIa Trial of SPL026

GlobeNewswire April 4, 2023

Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry

GlobeNewswire March 7, 2023

Small Pharma Announces Further Positive Data from SPL026 Phase IIa Trial in Major Depressive Disorder Strengthening Topline Efficacy Results

GlobeNewswire March 7, 2023